Oncology Pharmacy Services, Inc
Specialty Pharmacy
500 W 3rd St, Odessa
Texas, 79761-5010
432-337-0012 432-332-5353
Oncology Pharmacy Services, Inc is an authorized DME supplier for medicare equipments and products.
Oncology Pharmacy Services, Inc is a Specialty Pharmacy in Odessa, Texas. It is located at 500 W 3rd St, Odessa and it's customer support contact number is 432-337-0012. The authorized person of Oncology Pharmacy Services, Inc is J Ernest Sims who is Executive Director of the pharmacy and his contact number is 972-490-2912. Oncology Pharmacy Services, Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Oncology Pharmacy Services, Inc is a pharmacy that dispenses generally low volume and high cost medicinal preparations to patients who are undergoing intensive therapies for illnesses that are generally chronic, complex and potentially life threatening. Often these therapies require specialized delivery and administration.
Pharmacy Details:
Oncology Pharmacy Services, Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Oncology Pharmacy Services, Inc |
| Type: | Specialty Pharmacy |
| Location: | 500 W 3rd St, Odessa, Texas, 79761-5010 |
| Phone: | 432-337-0012 |
| Fax: | 432-332-5353 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | J Ernest Sims |
| Position: | Executive Director |
| Contact Number: | 972-490-2912 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1952443426 |
| NPI Enumeration Date: | 13 Feb, 2007 |
| NPI Last Update On: | 12 Jan, 2024 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Oncology Pharmacy Services, Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Specialty Pharmacy | | | Primary | |
| Pharmacy | | | Secondary | |
| Community/Retail Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 25336 | Other | Texas | Class A License |
| 466397 | Other | Texas | Hhsc Vendor |
| 4544018 | Other | Texas | Ncpdp |
Medicare Enrollment:
Oncology Pharmacy Services, Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 6002937190 | O20100930070779 | Oncology Pharmacy Services Inc | DME SUPPLIER - PHARMACY |
Products Available:
Oncology Pharmacy Services, Inc has following products available for sale under medicare.
| Products: |
|---|
| • Infusion Pumps & Supplies: External Infusion | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Po Box 731145, Dallas, Texas |
| Zip: | 75373-1145 |
| Phone Number: | 972-997-8103 |
| Fax Number: | 469-467-2535 |
Patients can reach Oncology Pharmacy Services, Inc at
500 W 3rd St, Odessa, Texas or can
call on customer care at 432-337-0012.
Comments/ Reviews:
Read all the reviews posted for Oncology Pharmacy Services, Inc below. You may also share your own experience with Oncology Pharmacy Services, Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.